广康生化
(300804)
| 流通市值：7.17亿 | | | 总市值：19.28亿 |
| 流通股本：2750.00万 | | | 总股本：7400.00万 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 121,030,292.39 | 220,250,332.06 | 432,500,005.74 | 368,001,654.71 |
| 应收票据及应收账款 | 232,744,298.04 | 229,975,820.15 | 223,345,134.76 | 206,532,666.51 |
| 其中：应收票据 | 35,230,733.78 | 34,746,313.43 | 23,758,672.02 | 67,180,528.6 |
| 应收账款 | 197,513,564.26 | 195,229,506.72 | 199,586,462.74 | 139,352,137.91 |
| 应收款项融资 | 1,236,127.15 | 6,226,299.78 | 4,443,383.14 | 5,628,634.65 |
| 预付款项 | 11,531,121.23 | 18,074,985.3 | 27,968,367.65 | 14,717,747.45 |
| 其他应收款合计 | 6,258,158.76 | 5,301,669.59 | 7,239,754.02 | 19,427,582.58 |
| 其中:应收利息 | 860,694.44 | 154,033.33 | 981,388.89 | - |
| 存货 | 192,834,181.42 | 189,580,244.58 | 147,309,536.61 | 156,465,501.05 |
| 其他流动资产 | 53,660,185.5 | 49,437,295.99 | 42,559,017.61 | 92,922,137.62 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,039,294,364.49 | 1,068,846,647.45 | 995,365,199.53 | 998,745,530.4 |
| 非流动资产: | | | | |
| 固定资产 | 494,324,585.69 | 507,368,989.05 | 495,500,254.17 | 508,508,240.22 |
| 在建工程 | 159,272,522.75 | 141,503,543.52 | 134,615,935.54 | 110,259,466.14 |
| 使用权资产 | 2,971,905.35 | 3,298,811.36 | 3,625,717.37 | 3,952,623.38 |
| 无形资产 | 152,430,782.82 | 153,908,983.78 | 155,033,897.8 | 153,528,433.89 |
| 长期待摊费用 | 4,759,285.16 | 5,223,290.57 | 4,938,501.15 | 4,751,612.43 |
| 递延所得税资产 | 8,899,157.37 | 7,285,330.79 | 5,976,145.37 | 6,111,620.29 |
| 其他非流动资产 | 43,375,394.67 | 40,326,203.1 | 46,745,816.62 | 45,244,769.71 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 866,033,633.81 | 858,915,152.17 | 846,436,268.02 | 832,356,766.06 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,905,327,998.3 | 1,927,761,799.62 | 1,841,801,467.55 | 1,831,102,296.46 |
| 流动负债: | | | | |
| 短期借款 | 192,383,421.61 | 214,155,644.72 | 182,484,606.87 | 217,337,131.55 |
| 应付票据及应付账款 | 225,357,238.93 | 245,140,945.37 | 242,433,417.31 | 206,739,123.4 |
| 其中：应付票据 | 110,508,276.7 | 133,484,543.05 | 137,759,152.49 | 106,108,139.43 |
| 应付账款 | 114,848,962.23 | 111,656,402.32 | 104,674,264.82 | 100,630,983.97 |
| 合同负债 | 7,770,916.07 | 5,623,251.82 | 8,448,345.29 | 13,120,720.9 |
| 应付职工薪酬 | 11,035,018.36 | 10,614,033.62 | 9,688,218.95 | 9,348,183.13 |
| 应交税费 | 5,387,454.72 | 3,443,251.76 | 2,114,373.63 | 224,416.67 |
| 其他应付款合计 | 787,024.84 | 1,035,124.7 | 855,056.38 | 1,091,125.59 |
| 一年内到期的非流动负债 | 18,391,520.31 | 22,817,179.82 | 35,462,679.51 | 40,450,714.94 |
| 其他流动负债 | 389,382.77 | 508,779.61 | 735,088.17 | 1,186,668.36 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 461,501,977.61 | 503,338,211.42 | 482,221,786.11 | 489,498,084.54 |
| 非流动负债: | | | | |
| 长期借款 | 102,496,662.38 | 103,319,338.12 | 40,598,004.14 | 41,567,485.44 |
| 租赁负债 | 1,595,927.21 | 1,397,038.6 | 2,745,661.64 | 2,716,923.65 |
| 预计负债 | 266,502.97 | 343,076.64 | 1,234,315.72 | 1,469,037.21 |
| 递延收益 | 22,370,327.72 | 4,095,968.15 | 4,385,575.25 | 4,675,182.35 |
| 递延所得税负债 | 4,811,189.33 | 5,069,076.02 | 5,351,107.02 | 5,547,512.01 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 131,540,609.61 | 114,224,497.53 | 54,314,663.77 | 55,976,140.66 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 593,042,587.22 | 617,562,708.95 | 536,536,449.88 | 545,474,225.2 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 74,000,000 | 74,000,000 | 74,000,000 | 74,000,000 |
| 资本公积 | 846,354,963.6 | 846,207,288.36 | 846,059,613.12 | 845,911,937.88 |
| 专项储备 | 1,291,433.47 | 987,951.85 | 350,959.91 | 0 |
| 盈余公积 | 49,011,930.69 | 49,011,930.69 | 49,011,930.69 | 49,011,930.69 |
| 未分配利润 | 340,395,259.97 | 338,663,289.82 | 334,374,455.25 | 316,704,202.69 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,311,053,587.73 | 1,308,870,460.72 | 1,303,796,958.97 | 1,285,628,071.26 |
| 少数股东权益 | 1,231,823.35 | 1,328,629.95 | 1,468,058.7 | - |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,312,285,411.08 | 1,310,199,090.67 | 1,305,265,017.67 | 1,285,628,071.26 |
| 负债和股东权益合计 | 1,905,327,998.3 | 1,927,761,799.62 | 1,841,801,467.55 | 1,831,102,296.46 |
| 公告日期 | 2024-10-25 | 2024-08-29 | 2024-04-26 | 2024-04-26 |
| 审计意见(境内) | | | | 标准无保留意见 |